Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Biguanide

Generic Name: Biguanide

Drug Type: Small Molecule

Chemical Formula: C_₂H_₇N_₅

CAS Number: 56-03-1

Unique Ingredient Identifier: FB4Q52I9K2

Overview

Biguanide has been investigated for the treatment of Diabetes Mellitus.

Background

Biguanide has been investigated for the treatment of Diabetes Mellitus.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Parasitic Ulcer Treatment Trial

Phase 3

Recruiting

Posted: 2024/01/19

Sponsor:

Jeremy Keenan, MD, M...

ID:NCT06213649

Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes

Phase 3

Completed

Posted: 2013/09/12

Sponsor:Sanofi

ID:NCT01940965

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

Phase 3

Completed

Posted: 2013/01/28

Sponsor:GlaxoSmithKline

ID:NCT01777282

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

Phase 3

Completed

Posted: 2012/04/24

Sponsor:Eli Lilly and Compan...

ID:NCT01584232

Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes

Phase 3

Completed

Posted: 2011/02/23

Sponsor:Mitsubishi Tanabe Ph...

ID:NCT01301833

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy